| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Cellular Endocrinology Laboratory, Department of Medicine, Compostela University School of Medicine and Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
Address all correspondence and requests for reprints to: Dr. F. F. Casanueva, P.O. Box 563, 15780 Santiago de Compostela, Spain. E-mail: meffcasa{at}uscmail.usc.es
In vivo FFA block basal and stimulated GH secretion and have been implicated in the pathogenesis of the altered GH secretion present in obesity and Cushings syndrome. Although a direct action on the somatotroph cell has been postulated, the FFA mechanism of action is unknown. The main biological target for FFA action is the cellular membrane, and it has been shown that these metabolites can block the activity of a number of plasma membrane pumps, channels, and receptor systems. In the present work, it was observed using different types of pituitary cells (GH3, GH4C1, and rat pituitary primary cultures) that cis-unsaturated fatty acids, such as oleic, 1) do not perturb TRH binding or the homologous desensitization of the TRH receptor; 2) inhibit TRH-induced inositol 1,4,5-trisphosphate/diacylglycerol generation, probably by a direct perturbation of phospholipase C; 3) reduce the TRH-induced intracellular Ca2+ redistribution and the ensuing changes in membrane potential; 4) completely inhibit the [Ca2+]i rise due to the TRH-induced opening of voltage-gated Ca2+ channels; and 5) abolish the TRH-induced Ca2+ efflux through plasma membrane Ca2+ pumps. These results suggest that cis-unsaturated FFA such as oleic acid selectively perturb the function of integral membrane proteins such as enzymes, channels, and pumps without perturbing the binding of ligands to receptors.
This article has been cited by other articles:
![]() |
K. A. Stokes, C. Tyler, and K. L. Gilbert The growth hormone response to repeated bouts of sprint exercise with and without suppression of lipolysis in men J Appl Physiol, March 1, 2008; 104(3): 724 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kok, M. M. Buijs, S. W. Kok, I. H. A. P. van Ierssel, M. Frolich, F. Roelfsema, P. J. Voshol, A. E. Meinders, and H. Pijl Acipimox enhances spontaneous growth hormone secretion in obese women Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R693 - R698. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lee, W. R. Duan, T. Kotlar, and J. L. Jameson Restoration of Growth Hormone-Releasing Hormone (GHRH) Responsiveness in Pituitary GH3 Cells by Adenovirus-Directed Expression of the Human GHRH Receptor Endocrinology, January 1, 2001; 142(1): 414 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sytze van Dam, H. E. C. Smid, W. R. de Vries, M. Niesink, E. Bolscher, E. J. Waasdorp, C. Dieguez, F. F. Casanueva, and H. P. F. Koppeschaar Reduction of Free Fatty Acids By Acipimox Enhances the Growth Hormone (GH) Responses to GH-Releasing Peptide 2 in Elderly Men J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4706 - 4711. [Abstract] [Full Text] |
||||
![]() |
J. P. Camina, X. Casabiell, and F. F. Casanueva Inositol 1,4,5-Trisphosphate-independent Ca2+ Mobilization Triggered by a Lipid Factor Isolated from Vitreous Body J. Biol. Chem., October 1, 1999; 274(40): 28134 - 28141. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Briard, M. Rico-Gomez, V. Guillaume, N. Sauze, V. Vuaroqueaux, F. Dadoun, Y. Le Bouc, C. Oliver, and A. Dutour Hypothalamic Mediated Action of Free Fatty Acid on Growth Hormone Secretion in Sheep Endocrinology, December 1, 1998; 139(12): 4811 - 4819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leal-Cerro, L. M. Jimenez, R. Astorga, I. Fernandez-Lopez, C. Dieguez, and F. F. Casanueva Acute Pharmacological Reduction of Plasma Free Fatty Acids Enhances the Growth Hormone (GH)-Releasing Hormone-Mediated GH Secretion in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3165 - 3168. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |